Why We Need a 10x Shift in Clinical Trials
We’ve accepted 10-year drug cycles as an unchangeable fact of life.Continue reading on Medium »
Artificial Intelligence, biotech, Biotechnology, clinical trials, virtual-humans
biotech
Artificial Intelligence, bioprinting, biotech, deeptech
Bio-printing Is Not a Hype Story. It Is a Bottleneck Story.
Deep Tech Is Not About Big Claims. It Is About Owning the Control Point.Continue reading on Medium »
Artificial Intelligence, biotech, future-of-medicine, healthcare, neurotechnology
The Medical Matrix: How AI and Biology are Merging to Cure the Incurable
Looking at the landscape of 2026, we’ve hit a critical inflection point with artificial intelligence. We aren’t just talking about…Continue reading on Medium »
Artificial Intelligence, biotech, cryptocurrency, decentralization, Pharma
A Decentralized Network Just Found Drug Candidates Faster Than Pharma
The average drug takes 10 years and 2.6 billion dollars to bring to market.Continue reading on Medium »
ai, ai music, Aloe Blacc, biotech, Biotech & Health, cancer research, drug-discovery, Media & Entertainment, music-industry, pancreatic cancer, Startups
The musician-turned-biotech-founder waiting to fundraise
When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a che…
Artificial Intelligence, biotech, Biotechnology, Nanotechnology, robotics
The Very First Sin
## I. GenesisContinue reading on Medium »
App, biotech, Biotechnology and health, The Big Story
Inside the stealthy startup that pitched brainless human clones
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired, R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal…